Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 0 composition records across product categories including unclassified products.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 0 composition records across product categories including unclassified products. EPA CPDat classifies this chemical for functional uses including Thickening agent.
US
FDA
Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.25 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 1 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.05 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.35 %w/w
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 11.8 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 20 mg